US$ 20.65
aod9604 human clinical trials weight loss results Does peptide demonstrate effective fat in humans? The Journey of AOD-9604: From
Description
Unlike traditional growth hormone therapy, AOD-9604 does not significantly increase growth hormone or IGF-1 levels

High-intensity exercise shifts fuel utilization toward glycogen, reducing the advantage of the pre-mobilized fatty acids

AOD 9604 doesn't affect IGF-1 levels, so there's no concern about unwanted tissue growth or increased cancer risk

Once the body adapts to running on mobilized fat stores rather than relying solely on dietary glucose, energy levels often stabilize at or above baseline
